Escolar Documentos
Profissional Documentos
Cultura Documentos
Manuscript Draft
The determination of PAHs has been mainly aimed at their hydroxylated metabolites while
few contributions for determining unmetabolized parent PAHs in urine samples have been
reported to date. Most of the methods are based on chromatographic separation, implying
long times of analysis. However, the use non-separative methodologies has not been
particularly explored for the analysis of PAHs in urines.
To our knowledge, this is the first time a programmed temperature vaporizer coupled with
quadrupole mass spectrometer has been used to analyse unmetabolized PAHs in urine
samples without chromatographic separation.
*Highlights (for review)
10
11
12
13
14
15
16
17
18
19
20
21
22
23
*Manuscript
Click here to view linked References
1 Table 1
2 Number of optimum PLS factors and relative predictive error (E %) in the calibration
3 step (cross-validation) with all the m/z variables and with the m/z selected by the
4 Martens uncertainty criterion. The relative predictive error (E %) and bias when the
5 optimum PLS1 models were used to predict the external validation set are also shown.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 Table 2
26 Repeatability, reproducibility and multivariate detection limits.
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50 Table 3
51 Misclassification of samples in the training set when PCA-LDA is used. The results
52 obtained with the best model are in bold.
PCs False positives False negatives % Correct assignation
3 2 0 93
4 2 0 93
5 0 0 100
6 0 0 100
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
Figure
All the m/z variables (35-300) Martens uncertainty criterion External validation set
Predicted concentration /(µg L-1 )
A B C
20 20 20
15 15 15
10 10 10
5 5 5
5 10 15 20 5 10 15 20 5 10 15 20
10
11
12
13
14
15
16
17
18
Figure
0,12
0.12
0,10
0,08
0.08
0,06
PC3 (13 %)
0,04
0.04
Z Axis
0,02
0,00
0.00
-0,02
-0,04
-0.02
-0,06
-0,20
-0,18
-0,16
-0,14
-0,12
-0,10
-0,08
-0,06
X A-0,04
-0,02
x0,00
i0,02
s 0,15
0,04 0,10
0,06 0,05
0,08 0,00
0,10 -0,05
0,12 -0,10
-0,15
is
Ax
Y
1
2 Fig. 2.
3
10
11
12
13
14
15
16
17
18
19
20
Figure
10
11
12
13
14
15
16
17
18
Figure
A
35
290 296 1 41 47
284 53
278 59
272 0.6
X variables
65
266 71 (m/z 35-300)
260 0.2 77
254 83
-0.2
248 89
PC1
X loadings
242 -0.6
95
PC1
236 -1 101 PC2
PC1
PC1PC1
230 107 PC1
PC2
PC2
PC2
224 113
PC2
PC3
PC2
218
PC3
PC3
PC3
PC3
119
212 125
PC3
206 131
200 137
194 143
188 149
182
176 170 167 161 155
B
Distance to non-spiked urine samples
-10
-20
-30
-40
-50
-50 -40 -30 -20 -10 0
10
Figure
-1
-2
Non-spiked urines Spiked urines
1
2 Fig. 5.
3
10
11
12
13
14
15
16
17
Supplementary Material
Click here to download Supplementary Material: Supplementary information.docx
*Graphical Abstract (for review)
Concentration of compound 2
PTV qMS
QUANT ITATIVE
Experimental
ANALYSIS
design
+
Multivariate
Mass spectrum calibration
Concentration of compound 1
QUALITATIVE
ANALYSIS
Pattern
Profile signal recognition
techniques
LLE